Shukra Pharmaceuticals Q2 Results

  • BSE: 524632
  • NSE: -
  • ISIN: INE551C01028
  • Sector: Biotechnology & Drugs
BSE
60.641.74 (2.95%)
Volume17.35 K
Updated: Mon 25 Nov, 2024 | 15:29:47
NSE
This stock is not traded on NSE
Today: 57.60
61.79
52-Wk: 21.29
129.90

Q2 Results Highlights

  • Total Income
    ₹5.56 Cr.
    (74.80%)
  • Operating Profit
    ₹-0.03 Cr.
    (NA%)
  • Profit After Tax
    ₹0.54 Cr.
    (11.04%)
  • Operating Margin
    -0.57%
    (NA%)
Note: Comparison is on YoY basis

Quarterly - Shukra Pharmaceuticals Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 5.5620.16-%24.64-%
Selling/ General/ Admin Expenses Total 1.43--%1.37-%
Depreciation/ Amortization 0.700.46-%0.56-%
Other Operating Expenses Total 1.080.57-%0.50-%
Total Operating Expense 5.5918.94-%20.11-%
Operating Income -0.031.22-%4.53-%
Net Income Before Taxes 0.870.43-%4.70-%
Net Income 0.540.42-%4.71-%
Diluted Normalized EPS 0.120.15-%1.09-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts